2026-04-05T16:30:11Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/ahcrr.000027 2020-11-24 PTZ.AHCRR:VOL5

Steroid Treatment in Hematologic Patients with COVID-19: Experience of 2 cases Jlal Bathish Ayat Zabida Lihie Eisenberg Lee Cohen Ben-MeirAliza Zeidman<p>On March 2020, Hasharon hospital reopened as the first and solely COVID-19 hospital in Israel. For six weeks 52 positive COVID-19 patients were admitted to our ward, Corona B ward. According to previous publications, patients with coexisting hematological condition were more vulnerable to COVID-19 complications. In particular, corticosteroids treatment was reported to reduce the cytokine storm complication of COVID-19. Yet, the literature regarding corticosteroids treatment was controversial at that time. We present two positive COVID-19 hemato-oncologic patients with successful treatment with corticosteroids: a patient with active Chronic Lymphocytic Leukemia (CLL) and a patient with Hodgkin Lymphoma (HL). Epidemiological, clinical, laboratory, imaging and treatment course are discussed along with the relevant literature.&nbsp;</p> Archives of Hematology Case Reports and Reviews - Peertechz Publications 2020-11-24 Case Report https://doi.org/10.17352/ahcrr.000027 en Copyright © Jlal Bathish et al.